Artisan Partners Limited Partnership cut its stake in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 0.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,211,946 shares of the technology company’s stock after selling 4,842 shares during the period. Artisan Partners Limited Partnership owned about 0.74% of Veeva Systems worth $361,051,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also bought and sold shares of the company. Sivia Capital Partners LLC boosted its stake in Veeva Systems by 225.9% in the second quarter. Sivia Capital Partners LLC now owns 3,122 shares of the technology company’s stock valued at $899,000 after acquiring an additional 2,164 shares in the last quarter. Legacy Investment Solutions LLC purchased a new stake in Veeva Systems in the second quarter valued at approximately $32,000. Ashton Thomas Private Wealth LLC acquired a new stake in shares of Veeva Systems in the second quarter worth $261,000. Bessemer Group Inc. grew its position in Veeva Systems by 32.9% during the 2nd quarter. Bessemer Group Inc. now owns 3,162 shares of the technology company’s stock worth $911,000 after purchasing an additional 783 shares during the period. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd acquired a new stake in Veeva Systems during the second quarter worth about $341,000. 88.20% of the stock is owned by institutional investors.
Trending Headlines about Veeva Systems
Here are the key news stories impacting Veeva Systems this week:
- Positive Sentiment: Company authorized a new ~US$2 billion share buyback and analysts have recently revised some estimates upward, supporting renewed investor focus on valuation and capital return. This buyback is being cited as a main catalyst for renewed demand. A Look At Veeva Systems (VEEV) Valuation
- Positive Sentiment: Veeva launched “eSource” to streamline clinical-trial data capture — a product extension that can expand stickiness with life-sciences customers and support subscription revenue growth. Product launches that improve workflow integration are generally positive for recurring SaaS sales. Veeva Systems Inc. (VEEV) Launches eSource
- Positive Sentiment: Market headlines and broad sector flows have highlighted Veeva as a top mover today, helping momentum-driven buying. General coverage pointing to the stock “skyrocketing” has likely amplified intraday demand. Veeva Systems, Upstart, Paycom, Commvault, and Agilysys shares skyrocket
- Neutral Sentiment: Stifel trimmed its price target (from $320 to $212) but retained a Buy rating, signaling mixed analyst sentiment: lower upside expectations but continued buy-side endorsement. Stifel price target change
- Neutral Sentiment: Coverage pieces (Zacks, recent market summaries) note Veeva as a trending name — raising attention but not changing fundamentals by itself. Veeva trending stock note
- Negative Sentiment: Multiple broker price targets were lowered recently (Barclays, Oppenheimer among them), reflecting more cautious medium-term estimates even as most maintain constructive ratings — a headwind for valuation. Barclays price target note Oppenheimer lowers price target
- Negative Sentiment: Short interest rose ~26% in February to roughly 6.33M shares (about 4.3% of float), increasing bearish pressure and potential volatility should sentiment change. (Data reported Feb 13.)
Insider Activity
Veeva Systems Price Performance
Shares of VEEV opened at $182.84 on Friday. Veeva Systems Inc. has a 1-year low of $168.13 and a 1-year high of $310.50. The stock has a market cap of $30.06 billion, a PE ratio of 35.57, a price-to-earnings-growth ratio of 1.22 and a beta of 1.08. The firm has a fifty day moving average price of $207.69 and a 200 day moving average price of $251.18.
Veeva Systems announced that its Board of Directors has authorized a stock buyback program on Monday, January 5th that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the technology company to repurchase up to 5.5% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s board of directors believes its shares are undervalued.
Wall Street Analyst Weigh In
VEEV has been the subject of several recent analyst reports. BTIG Research restated a “buy” rating and issued a $340.00 price target on shares of Veeva Systems in a research note on Friday, November 21st. Needham & Company LLC restated a “buy” rating and set a $355.00 price target on shares of Veeva Systems in a research report on Friday, November 21st. Oppenheimer lowered their price objective on Veeva Systems from $325.00 to $275.00 and set an “outperform” rating on the stock in a research note on Tuesday. UBS Group cut their price target on shares of Veeva Systems from $280.00 to $200.00 and set a “neutral” rating for the company in a report on Friday, February 20th. Finally, Robert W. Baird upped their target price on shares of Veeva Systems from $314.00 to $319.00 and gave the company an “outperform” rating in a research report on Friday, November 21st. Eighteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $293.71.
View Our Latest Report on Veeva Systems
About Veeva Systems
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Featured Articles
- Five stocks we like better than Veeva Systems
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
